{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Inhibrx Biosciences, Inc."},"Symbol":{"label":"Symbol","value":"INBX"},"Address":{"label":"Address","value":"11025 N. TORREY PINES ROAD,SUITE 140, CALIFORNIA, 92037, United States"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence."},"CompanyUrl":{"label":"Company Url","value":"https://inhibrx.com/"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Ashraf Amanullah","title":"Chief Technical Operations Officer & Executive VP"},{"name":"Brendan P. Eckelman","title":"Chief Scientific Officer & Executive VP"},{"name":"Josep Garcia","title":"Chief Clinical Development Officer & Executive VP"},{"name":"Mark Paul Lappe","title":"Chairman, President & Chief Executive Officer"},{"name":"Robert Boothroyd","title":"VP-Medical Affairs & Business Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}